##gff-version 3
##sequence-region Q92908 1 595
Q92908	UniProtKB	Chain	1	595	.	.	.	ID=PRO_0000083423;Note=Transcription factor GATA-6	
Q92908	UniProtKB	Zinc finger	390	414	.	.	.	Note=GATA-type 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00094	
Q92908	UniProtKB	Zinc finger	444	468	.	.	.	Note=GATA-type 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00094	
Q92908	UniProtKB	Compositional bias	173	183	.	.	.	Note=Poly-Ala	
Q92908	UniProtKB	Compositional bias	324	333	.	.	.	Note=Poly-His	
Q92908	UniProtKB	Compositional bias	449	453	.	.	.	Note=Poly-Thr	
Q92908	UniProtKB	Modified residue	268	268	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q92908	UniProtKB	Cross-link	429	429	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q92908	UniProtKB	Cross-link	473	473	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q92908	UniProtKB	Cross-link	484	484	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q92908	UniProtKB	Alternative sequence	1	146	.	.	.	ID=VSP_035778;Note=In isoform 2. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:8975704,ECO:0000303|PubMed:9294001,ECO:0000303|PubMed:9315713;Dbxref=PMID:8975704,PMID:9294001,PMID:9315713	
Q92908	UniProtKB	Natural variant	15	15	.	.	.	ID=VAR_067380;Note=G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19666519,ECO:0000269|PubMed:20581743,ECO:0000269|PubMed:20631719,ECO:0000269|PubMed:22750565;Dbxref=dbSNP:rs116262672,PMID:19666519,PMID:20581743,PMID:20631719,PMID:22750565	
Q92908	UniProtKB	Natural variant	91	91	.	.	.	ID=VAR_078427;Note=Probable disease-associated mutation found in patients with atrial fibrillation%3B gain of function%3B no effect on subcellular localization. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27756709;Dbxref=dbSNP:rs766886560,PMID:27756709	
Q92908	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_078428;Note=Probable disease-associated mutation found in patients with atrial fibrillation%3B gain of function%3B no effect on subcellular localization. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27756709;Dbxref=dbSNP:rs1263887431,PMID:27756709	
Q92908	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_067381;Note=In AVSD5%3B increased transcriptional activity. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20581743;Dbxref=dbSNP:rs387906815,PMID:20581743	
Q92908	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_067382;Note=In ASD9 and TOF%3B loss of transcriptional activity. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20631719;Dbxref=dbSNP:rs387906816,PMID:20631719	
Q92908	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_067383;Note=In TOF%3B uncertain pathological significance%3B does not affect transcriptional activity. L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20581743;Dbxref=dbSNP:rs387906814,PMID:20581743	
Q92908	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_078429;Note=Probable disease-associated mutation found in patients with atrial fibrillation%3B significant loss of transcriptional activator activity. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22750565;Dbxref=PMID:22750565	
Q92908	UniProtKB	Natural variant	452	452	.	.	.	ID=VAR_067384;Note=In PACHD. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22158542;Dbxref=dbSNP:rs387906817,PMID:22158542	
Q92908	UniProtKB	Natural variant	456	456	.	.	.	ID=VAR_067385;Note=In PACHD%3B loss of transcriptional activity. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22158542;Dbxref=dbSNP:rs387906818,PMID:22158542	
Q92908	UniProtKB	Natural variant	456	456	.	.	.	ID=VAR_067386;Note=In PACHD. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22158542;Dbxref=dbSNP:rs387906819,PMID:22158542	
Q92908	UniProtKB	Natural variant	466	466	.	.	.	ID=VAR_067387;Note=In PACHD%3B loss of transcriptional activity. N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22158542;Dbxref=dbSNP:rs387906813,PMID:22158542	
Q92908	UniProtKB	Natural variant	466	466	.	.	.	ID=VAR_067388;Note=In CTHM%3B persistent truncus arteriosus%3B loss of transcriptional activity. N->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19666519;Dbxref=dbSNP:rs387906813,PMID:19666519	
Q92908	UniProtKB	Natural variant	467	467	.	.	.	ID=VAR_067389;Note=In PACHD%3B loss of transcriptional activity. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22158542;Dbxref=dbSNP:rs387906820,PMID:22158542	
Q92908	UniProtKB	Natural variant	469	469	.	.	.	ID=VAR_078430;Note=Probable disease-associated mutation found in patients with atrial fibrillation%3B significant loss of transcriptional activator activity. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22824924;Dbxref=PMID:22824924	
Q92908	UniProtKB	Natural variant	473	473	.	.	.	ID=VAR_067390;Note=In PACHD%3B loss of transcriptional activity. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22158542;Dbxref=PMID:22158542	
Q92908	UniProtKB	Natural variant	543	543	.	.	.	ID=VAR_078431;Note=Probable disease-associated mutation found in patients with atrial fibrillation%3B gain of function%3B no effect on subcellular localization. A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27756709;Dbxref=dbSNP:rs761668180,PMID:27756709	
Q92908	UniProtKB	Natural variant	585	585	.	.	.	ID=VAR_078432;Note=Probable disease-associated mutation found in patients with atrial fibrillation%3B gain of function%3B no effect on subcellular localization. R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27756709;Dbxref=dbSNP:rs201707559,PMID:27756709	
Q92908	UniProtKB	Sequence conflict	281	281	.	.	.	Note=G->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
